Skip to main content
. 2022 Jan 11;8:730577. doi: 10.3389/fmed.2021.730577

Figure 5.

Figure 5

(A) The prevalence of the different genomic SARS-CoV-2 variants detected in the study. (B) Dynamics of SARS-CoV-2 genomic variants identified in the Nice Metropolitan area (France) from September 21, 2020 to March 18, 2021.